ANX-042 / Mayo Clinic, Anexon  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ANX-042 / Anexon
NCT01638104: ANX-042 Healthy Volunteer Dose Escalation Study

Completed
1
30
US
ANX-042, Placebo
Mayo Clinic, Anexon, Incorporated, Celerion
Healthy Volunteers
12/12
12/12
ANX-042 Aim 1, NCT03019653: Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

Enrolling by invitation
1
60
US
ANX-042, Placebo
Mayo Clinic, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Heart Failure, Cardiorenal Disease, Renal Disfunction
12/24
12/24

Download Options